NCT06399705

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2024-10-02Est. Completion: 2033-03-15

Enrollment target: 600 participants

Locations

Adventist Health Glendale, Glendale, California, United States
Emory University, Atlanta, Georgia, United States
Ascension St. Vincent Cardiovascular Research Institute, Carmel, Indiana, United States
Baptist Health Lexington, Lexington, Kentucky, United States
Baptist Health Louisville, Louisville, Kentucky, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Englewood Hospital, Englewood, New Jersey, United States
NewYork-Presbyterian Hospital - Queens, Flushing, New York, United States
Icahn School of Medicine - Mount Sinai Morningside, New York, New York, United States
Icahn School of Medicine - Mount Sinai Hospital, New York, New York, United States
Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States
Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York, United States
Westchester Medical Center, Valhalla, New York, United States
Duke University, Durham, North Carolina, United States
Ohio State University, Columbus, Ohio, United States

Systemic SclerosisScleroderma

The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…

Scottsdale, United StatesEst. completion Jan 6, 2027

Chronic Kidney DiseaseCoronary Arteries CalcificationsCXCR2 Expression

Chronic kidney disease (CKD) is associated with the development of coronary arteries calcifications (CAC) and increased …

Amiens, FranceEst. completion Aug 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.